As of November 6, 2026, Adagene Inc. is a publicly traded company (Nasdaq: ADAG). The largest holder reporting an active stake on Schedule 13D is Peter Luo, the chief executive and a director, at 11.2%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include Janus Henderson (10.1%), Smith Vincent C (8.7%), Chernett Jorey (5.1%) (Schedule 13D/A, June 8, 2026).
Is this your company?
About to sign with, pay or invest in Adagene Inc.? See the free Snapshot first.
Free to see. No signup.
Is Adagene Inc. a real, registered company?
- Adagene Inc. files with the SEC under CIK 1818838 (its SEC filings).
- Its shares are listed under the ticker ADAG on Nasdaq (SEC company record).
- Incorporated in E9; business address in Jiangsu, F4, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Adagene Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Peter Luo (filed 2026-06-08).
Who are Adagene Inc.'s owners and officers?
Adagene Inc.: business address in Jiangsu, F4; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-08-14).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | Wuxi Pharmatech Healthcare Fund I L.P. | 3.5% |
| Schedule 13D/A, 2026-06-08 | Peter Luo | 11.2% |
| Schedule 13G/A, 2026-05-15 | Wuxi Pharmatech Healthcare Fund I L.P. | 5.9% |
| Schedule 13G, 2026-05-07 | Janus Henderson Group PLC | 10.1% |
| Schedule 13G, 2026-03-18 | Chernett Jorey | 5.1% |
| Schedule 13G/A, 2026-02-17 | General Atlantic Singapore Fund Pte. LTD. | 0% |
| Schedule 13G/A, 2026-01-29 | Smith Vincent C | 8.7% |
| Schedule 13G/A, 2025-11-14 | Wuxi Pharmatech Healthcare Fund I L.P. | 7% |
| Schedule 13G/A, 2025-11-14 | Panacea Venture Healthcare Fund Ii, L.P. | 3.8% |
| Schedule 13G/A, 2025-07-02 | Fmr LLC | 0.9% |
Questions about who owns Adagene Inc.
Who owns Adagene Inc.?
On this page, 4 holders' latest ownership filings report 5% or more of Adagene Inc.: Peter Luo (11.2%, Schedule 13D/A, filed 2026-06-08), Janus Henderson Group PLC (10.1%, Schedule 13G, filed 2026-05-07), Smith Vincent C (8.7%, Schedule 13G/A, filed 2026-01-29) and Chernett Jorey (5.1%, Schedule 13G, filed 2026-03-18).
Who are the largest shareholders of Adagene Inc.?
By the share each holder's latest filing reports, the largest holders of Adagene Inc. on this page are Peter Luo (11.2%), Janus Henderson Group PLC (10.1%) and Smith Vincent C (8.7%).
When did Peter Luo buy into Adagene Inc.?
The filings give report dates, not purchase dates. The earliest filing from Peter Luo on this page is the Schedule 13D/A, filed 2026-06-08, reporting 11.2%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 10 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Adagene Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Adagene Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Adagene Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
16 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Adagene Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief strategy officer: 467,525 shares (0.79% of shares outstanding), 279,506 held directly and 188,019 indirectly (Form 3, 2026-03-18).
- , the chief manufacturing officer: 130,214 shares (0.22% of shares outstanding) (Form 3, 2026-03-18).
- , the chief executive and a director: 124,285 shares (0.21% of shares outstanding), 93,264 held directly and 31,021 indirectly (Form 3, 2026-03-18).
- , the chief financial officer and a director: 116,583 shares (0.20% of shares outstanding) (Form 3, 2026-03-18).
- , a director: 25,000 shares (0.04% of shares outstanding) (Form 3, 2026-03-17).
Shares outstanding: 59,231,993 as of 2025-12-31, from the company's latest SEC cover page.
How much has Adagene Inc. raised?
No fundraising or offering filing from Adagene Inc. is on file with us.
Keep reading
More on Adagene Inc. and the records around it.
Adagene Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
Companies that share a holder
- Panacea Venture Healthcare Fund II, L.P. also filed stake reports on 3 other companies: Atara Biotherapeutics, Inc. (May 2026), Connect Biopharma Holdings Limited (Apr 2026), CASI Pharmaceuticals, Inc. (Dec 2025)
- General Atlantic Singapore Fund Pte. Ltd. also filed stake reports on 10 other companies: Korsana Biosciences, Inc. (Sep 2026), dLocal Ltd (Aug 2026), Pharvaris N.V. (Aug 2026)
- Chernett Jorey also filed stake reports on 16 other companies: CVRx, Inc. (Oct 2026), WW INTERNATIONAL, INC. (Aug 2026), Neuronetics, Inc. (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/adagene